Riskpilot← Back to searchSign inGet full accessTECHNOMEDICS NORGE AS
ASActiveOrg 986392742Gramveien 68, 1832 AskimWholesale of pharmaceutical and medical goods · NACE 4646Est. 200417 employees
Revenue 2024
NOK 54,4M
+23% vs 2023
EBITDA margin
14.8%
+41% vs 2023
Equity ratio
25.9%
Financial strength
Net profit 2024
NOK 5,9M
+48% vs 2023
| Revenue | NOK 54,4M | +23% |
| EBITDA | NOK 8,1M | +41% |
| Net profit | NOK 5,9M | +48% |
| Total assets | NOK 23,4M | +35% |
| Equity | NOK 6M | +0% |
| Employees | 17 | — |
Legal name
TECHNOMEDICS NORGE AS
Org number
986392742
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8. januar 2004
Share capital
NOK 100 000
Employees
17 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Import og salg av dentale produkter og deltagelse i andre selskaper samt hertil hørende virksomhet.
Address
Gramveien 68, 1832 Askim
Phone
+4769887920
Email
firmapost@technomedics.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 31 721 | 38 956 | 42 954 | 44 439 | 54 448 |
| Staff expenses | −7 422 | −10 020 | −10 455 | −10 990 | −14 095 |
| EBITDA | 5 275 | 6 556 | 5 828 | 5 718 | 8 053 |
| Depreciation & amort. | −440 | −319 | −411 | −611 | −607 |
| EBIT | 4 835 | 6 236 | 5 417 | 5 107 | 7 446 |
| Net financials | 21 | 27 | 82 | 43 | 152 |
| Profit before tax | 4 856 | 6 263 | 5 498 | 5 150 | 7 598 |
| Tax | 1 069 | 1 382 | 1 223 | 1 141 | 1 680 |
| Net profit | 3 787 | 4 880 | 4 276 | 4 009 | 5 918 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 17 426 | 20 173 | 18 739 | 17 271 | 23 355 |
| Equity | 5 916 | 5 997 | 6 023 | 6 032 | 6 049 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11 509 | 14 176 | 12 716 | 11 239 | 17 306 |
| Total debt | 11 509 | 14 176 | 12 716 | 11 239 | 17 306 |
EBITDA margin
14.8%
This company
15.8%
Market median
-6% vs market
20202024
Equity ratio
25.9%
This company
38.2%
Market median
-32% vs market
20202024
Return on equity
97.8%
This company
18.4%
Market median
+432% vs market
20202024
Net profit margin
10.9%
This company
8.1%
Market median
+35% vs market
20202024
Asset turnover
2.33×
This company
1.12×
Market median
+108% vs market
20202024
Debt / equity
2.86×
This company
0.62×
Market median
-361% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
WO Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2020 | |
| Chairman | 2026 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lic Scadenta As
TECHNOMEDICS NORGE AS Board members of TECHNOMEDICS NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Widar Oscar William Taranrød | Chief Executive Officer | 0 companies |
| David Møller Knudsen | Board of Directors | 0 companies |
| Kristian Funderud Melby | Chairman | 0 companies |
| Frida Maria Agge | Board of Directors | 0 companies |
| Arild Haugeland | Chairman | 0 companies |